We’re excited to announce our next ISAM Webinar, featuring two emerging researchers in the field of respiratory science: Michael Neary, PhD candidate at University College Cork, Ireland, and Lucy Goodacre, PhD candidate, researcher at King’s College London and Nanopharm Ltd., UK.

Pulmonary and nasal drug delivery offer non-invasive alternatives for both local and systemic therapies. These routes enable rapid absorption, bypass first-pass metabolism, and support innovative approaches like RNA therapeutics and nose-to-brain delivery. Advances in formulation and in-vitro modelling are driving new possibilities in respiratory and neurological treatment.

This session presents two complementary approaches to non-invasive drug delivery - pulmonary administration of RNA therapeutics and advanced in-vitro modelling for nasal deposition. The presentations focus on how formulation design and experimental methodology influence delivery performance and inform early-stage research.

Key points:

*Delivery of siRNA via vibrating mesh nebulizers: formulation stability and gene silencing efficiency

*Comparative evaluation of lipid-based nanocarriers for pulmonary RNA delivery

*Development of thermoresponsive mucus simulants for nasal cast coating

*Strategies to improve reproducibility and physiological relevance in nasal deposition studies

*Refinement of in-vitro models to support intranasal drug development

 📅When:

Tuesday, 23rd September 2025; 8 am – 9 am (San Diego, CA); 11 am – 12 am (New York, NY); 5 pm – 6 pm (Paris, France)

Follow this link to register for the zoom meeting.